STAT+: Medicare is spending far less than expected on new Alzheimer’s drugs
Adoption has been slow with new Alzheimer’s drugs because the treatments are complicated to administer and the benefits are uncertain.
ORIGINAL SOURCE →via STAT News Health
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] UNDRR Regional Office for Arab States
- [CONFLICT] Digital security in war and conflict: challenges for civil society and tools for resilience
- [CONFLICT] Securing the Untrusted Agentic Development Layer
- [CONFLICT] İslam Memiş'ten altın yatırımcısına kritik uyarı: HAZIR OLUN
- [CONFLICT] MEB İL İÇİ YER DEĞİŞTİRME SONUÇLARI 2026 | Öğretmen İl İçi Tayin Sonuçları Açıklandı! Öğretmen Atama Listesi ve MEBBİS Ekranı